497 related articles for article (PubMed ID: 19812206)
21. Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis.
Carmi Y; Rinott G; Dotan S; Elkabets M; Rider P; Voronov E; Apte RN
J Immunol; 2011 Mar; 186(6):3462-71. PubMed ID: 21300825
[TBL] [Abstract][Full Text] [Related]
22. Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.
Bricard G; Cesson V; Devevre E; Bouzourene H; Barbey C; Rufer N; Im JS; Alves PM; Martinet O; Halkic N; Cerottini JC; Romero P; Porcelli SA; Macdonald HR; Speiser DE
J Immunol; 2009 Apr; 182(8):5140-51. PubMed ID: 19342695
[TBL] [Abstract][Full Text] [Related]
23. Natural killer T cells within the liver: conductors of the hepatic immune orchestra.
Swain MG
Dig Dis; 2010; 28(1):7-13. PubMed ID: 20460885
[TBL] [Abstract][Full Text] [Related]
24. Recombined CC chemokine ligand 2 into B16 cells induces production of Th2-dominant [correction of dominanted] cytokines and inhibits melanoma metastasis.
Hu K; Xiong J; Ji K; Sun H; Wang J; Liu H
Immunol Lett; 2007 Oct; 113(1):19-28. PubMed ID: 17868906
[TBL] [Abstract][Full Text] [Related]
25. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
26. Tuberous sclerosis 1 promotes invariant NKT cell anergy and inhibits invariant NKT cell-mediated antitumor immunity.
Wu J; Shin J; Xie D; Wang H; Gao J; Zhong XP
J Immunol; 2014 Mar; 192(6):2643-50. PubMed ID: 24532578
[TBL] [Abstract][Full Text] [Related]
27. Activation or anergy: NKT cells are stunned by alpha-galactosylceramide.
Sullivan BA; Kronenberg M
J Clin Invest; 2005 Sep; 115(9):2328-9. PubMed ID: 16138189
[TBL] [Abstract][Full Text] [Related]
28. Suppression of Con A-induced hepatitis induction in ICOS-deficient mice.
Watanabe S; Ohnuki K; Hara Y; Ishida Y; Ikarashi Y; Ogawa S; Kishimoto H; Tanabe K; Abe R
Immunol Lett; 2010 Jan; 128(1):51-8. PubMed ID: 19914290
[TBL] [Abstract][Full Text] [Related]
29. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors.
Biburger M; Tiegs G
J Leukoc Biol; 2008 Jul; 84(1):264-79. PubMed ID: 18407967
[TBL] [Abstract][Full Text] [Related]
30. Activation of pulmonary invariant NKT cells leads to exacerbation of acute lung injury caused by LPS through local production of IFN-γ and TNF-α by Gr-1+ monocytes.
Aoyagi T; Yamamoto N; Hatta M; Tanno D; Miyazato A; Ishii K; Suzuki K; Nakayama T; Taniguchi M; Kunishima H; Hirakata Y; Kaku M; Kawakami K
Int Immunol; 2011 Feb; 23(2):97-108. PubMed ID: 21172897
[TBL] [Abstract][Full Text] [Related]
31. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
[TBL] [Abstract][Full Text] [Related]
32. Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model.
Kee JY; Ito A; Hojo S; Hashimoto I; Igarashi Y; Tsukada K; Irimura T; Shibahara N; Nakayama T; Yoshie O; Sakurai H; Saiki I; Koizumi K
Oncol Rep; 2013 Mar; 29(3):975-82. PubMed ID: 23242131
[TBL] [Abstract][Full Text] [Related]
33. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
Hung JT; Huang JR; Yu AL
J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
[TBL] [Abstract][Full Text] [Related]
34. Valpha14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes.
Ohtaki H; Ito H; Ando K; Ishikawa T; Saito K; Imawari M; Yokochi T; Moriwaki H; Seishima M
Biochem Biophys Res Commun; 2009 Jan; 378(3):579-83. PubMed ID: 19056341
[TBL] [Abstract][Full Text] [Related]
35. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.
Bourgeois E; Van LP; Samson M; Diem S; Barra A; Roga S; Gombert JM; Schneider E; Dy M; Gourdy P; Girard JP; Herbelin A
Eur J Immunol; 2009 Apr; 39(4):1046-55. PubMed ID: 19266498
[TBL] [Abstract][Full Text] [Related]
36. Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment.
Ito D; Back TC; Shakhov AN; Wiltrout RH; Nedospasov SA
J Immunol; 1999 Sep; 163(5):2809-15. PubMed ID: 10453025
[TBL] [Abstract][Full Text] [Related]
37. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
[TBL] [Abstract][Full Text] [Related]
38. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
Mencarelli A; Renga B; Migliorati M; Cipriani S; Distrutti E; Santucci L; Fiorucci S
J Immunol; 2009 Nov; 183(10):6657-66. PubMed ID: 19880446
[TBL] [Abstract][Full Text] [Related]
39. Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.
Molling JW; Moreno M; van der Vliet HJ; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
J Immunol Methods; 2007 Apr; 322(1-2):70-81. PubMed ID: 17343874
[TBL] [Abstract][Full Text] [Related]
40. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
